These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38563194)

  • 1. Long-term outcome and prognostic value of angiographic slow/no-reflow phenomenon after emergency percutaneous coronary intervention for ST-elevation myocardial infarction.
    Bamarinejad A; Kermani-Alghoraishi M; Soleimani A; Roohafza H; Yazdekhasti S; MirmohammadSadeghi A; Bamarinejad F; Sadeghi M
    Coron Artery Dis; 2024 Aug; 35(5):389-396. PubMed ID: 38563194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MELD-XI score predict no-reflow phenomenon and short-term mortality in patient with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Zhang XT; Lin ZR; Zhang L; Zhao ZW; Chen LL
    BMC Cardiovasc Disord; 2022 Mar; 22(1):113. PubMed ID: 35300593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors and long-term prognosis of angiographic slow/no-reflow phenomenon during emergency percutaneous coronary intervention for ST-elevated acute myocardial infarction.
    Dong-bao L; Qi H; Zhi L; Shan W; Wei-ying J
    Clin Cardiol; 2010 Dec; 33(12):E7-12. PubMed ID: 21184547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New CHA
    Zhang QY; Ma SM; Sun JY
    BMC Cardiovasc Disord; 2020 Jul; 20(1):346. PubMed ID: 32711475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive value of admission red cell distribution width-platelet ratio for no-reflow phenomenon in acute ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Celık T; Balta S; Demır M; Yıldırım AO; Kaya MG; Ozturk C; Demırkol S; Unlu M; Kılıc S; Aydın İ; Iyısoy A
    Cardiol J; 2016; 23(1):84-92. PubMed ID: 26503078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of no-reflow phenomena after primary percutaneous coronary intervention: a time-dependent analysis of mortality.
    Choo EH; Kim PJ; Chang K; Ahn Y; Jeon DS; Lee JM; Kim DB; Her SH; Park CS; Kim HY; Yoo KD; Jeong MH; Seung KB
    Coron Artery Dis; 2014 Aug; 25(5):392-8. PubMed ID: 24625688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of no-reflow phenomenon following percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Aggarwal P; Rekwal L; Sinha SK; Nath RK; Khanra D; Singh AP
    Ann Cardiol Angeiol (Paris); 2021 Jun; 70(3):136-142. PubMed ID: 33962782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel predictors and adverse long-term outcomes of No-reflow phenomenon in patients with acute ST elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Refaat H; Tantawy A; Gamal AS; Radwan H
    Indian Heart J; 2021; 73(1):35-43. PubMed ID: 33714407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed angioplasty is superior to an emergency strategy in ST-segment elevation myocardial infarction patients who present late and with infarct artery spontaneous reperfusion before intervention.
    Li M; Wu Z; Yuan Y; Feng L; Lao Y; Guo Z
    Cardiovasc J Afr; 2019 May/Jun 23; 30(3):162-167. PubMed ID: 31144708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of fibrinogen-to-albumin ratio to predict no-reflow and short-term prognosis in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Zhao Y; Yang J; Ji Y; Wang S; Wang T; Wang F; Tang J
    Heart Vessels; 2019 Oct; 34(10):1600-1607. PubMed ID: 30993442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of Mean Platelet Volume-to-Lymphocyte Ratio for Predicting Angiographic No-Reflow and Short-Term Prognosis After Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction.
    Kurtul A; Acikgoz SK
    Am J Cardiol; 2017 Aug; 120(4):534-541. PubMed ID: 28633762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D level predicts angiographic no-reflow phenomenon after percutaneous coronary intervention in patients with ST segment elevation myocardial infarction.
    Şen Ö; Şen SB; Topuz AN; Topuz M
    Biomark Med; 2021 Oct; 15(15):1357-1366. PubMed ID: 34533051
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of GP IIb/IIIa inhibitor duration on the clinical prognosis of primary percutaneous coronary intervention in ST-segment elevation myocardial infarction with no-/slow-reflow phenomenon.
    Hu X; Wang W; Ye J; Lin Y; Yu B; Zhou L; Zhou Y; Dong H
    Biomed Pharmacother; 2021 Nov; 143():112196. PubMed ID: 34560551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-year prognostic value of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction.
    Ndrepepa G; Tiroch K; Fusaro M; Keta D; Seyfarth M; Byrne RA; Pache J; Alger P; Mehilli J; Schömig A; Kastrati A
    J Am Coll Cardiol; 2010 May; 55(21):2383-9. PubMed ID: 20488311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors and outcomes of no-reflow phenomenon in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Tasar O; Karabay AK; Oduncu V; Kirma C
    Coron Artery Dis; 2019 Jun; 30(4):270-276. PubMed ID: 31026233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum Endocan Levels Predict Angiographic No-Reflow Phenomenon in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Coronary Intervention.
    Dogdus M; Yenercag M; Ozyasar M; Yilmaz A; Can LH; Kultursay H
    Angiology; 2021 Mar; 72(3):221-227. PubMed ID: 32996338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Value of Pre-Infarction Angina Combined with Mean Platelet Volume to Lymphocyte Count Ratio for No-Reflow and Short-Term Mortality in Patients with ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention.
    Chen X; Meng Y; Shao M; Zhang T; Han L; Zhang W; Zhang H; Hai H; Li G
    Med Sci Monit; 2020 Jan; 26():e919300. PubMed ID: 31949123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated uric acid is related to the no-/slow-reflow phenomenon in STEMI undergoing primary PCI.
    Hu X; Yang X; Li X; Li G; Zhou Y; Dong H
    Eur J Clin Invest; 2022 Apr; 52(4):e13719. PubMed ID: 34800289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CHA2DS2-VASc Score is a Predictor of No-Reflow in Patients With ST-Segment Elevation Myocardial Infarction Who Underwent Primary Percutaneous Intervention.
    Ipek G; Onuk T; Karatas MB; Gungor B; Osken A; Keskin M; Oz A; Tanik O; Hayiroglu MI; Yaka HY; Ozturk R; Bolca O
    Angiology; 2016 Oct; 67(9):840-5. PubMed ID: 26685178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex-Related Differences in Short- and Long-Term Outcome among Young and Middle-Aged Patients for ST-Segment Elevation Myocardial Infarction Underwent Percutaneous Coronary Intervention.
    Fu WX; Zhou TN; Wang XZ; Zhang L; Jing QM; Han YL
    Chin Med J (Engl); 2018 Jun; 131(12):1420-1429. PubMed ID: 29893358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.